Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Nathan Peiffer-Smadja and Yazdan Yazdanpanah.
Nathan Peiffer-Smadja
Connection Strength
2.905
Yazdan Yazdanpanah
  1. Nebulised interferon beta-1a for patients with COVID-19. Lancet Respir Med. 2021 02; 9(2):122-123.
    View in: PubMed
    Score: 0.913
  2. Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2. Viruses. 2021 08 19; 13(8).
    View in: PubMed
    Score: 0.241
  3. COVID-19 vaccines: A race against time. Anaesth Crit Care Pain Med. 2021 04; 40(2):100848.
    View in: PubMed
    Score: 0.234
  4. Clinical trial protocols of repurposed prophylaxis for COVID-19: A review. Infect Dis Now. 2021 02; 51(1):7-13.
    View in: PubMed
    Score: 0.227
  5. Challenges and issues about organizing a hospital to respond to the COVID-19 outbreak: experience from a French reference centre. Clin Microbiol Infect. 2020 Jun; 26(6):669-672.
    View in: PubMed
    Score: 0.219
  6. Type 1 interferons as a potential treatment against COVID-19. Antiviral Res. 2020 06; 178:104791.
    View in: PubMed
    Score: 0.219
  7. A case of thoracic actinomycosis presenting as sudden paraplegia. Rev Neurol (Paris). 2019 Jan - Feb; 175(1-2):89-92.
    View in: PubMed
    Score: 0.197
  8. [The plague: An overview and hot topics]. Rev Med Interne. 2018 Nov; 39(11):863-868.
    View in: PubMed
    Score: 0.191
  9. Vaccination and blood sampling acceptability during Ramadan fasting month: A cross-sectional study in Conakry, Guinea. Vaccine. 2017 05 02; 35(19):2569-2574.
    View in: PubMed
    Score: 0.179
  10. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
    View in: PubMed
    Score: 0.059
  11. Corrigendum to "Review of trials currently testing treatment and prevention of COVID-19" [Clin Microbiol Infect 26.8 (2020) 988-998]. Clin Microbiol Infect. 2021 Mar; 27(3):499.
    View in: PubMed
    Score: 0.058
  12. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial-authors' response. J Antimicrob Chemother. 2021 01 01; 76(1):277-279.
    View in: PubMed
    Score: 0.058
  13. Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. J Antimicrob Chemother. 2020 09 01; 75(9):2376-2380.
    View in: PubMed
    Score: 0.056
  14. Review of trials currently testing treatment and prevention of COVID-19. Clin Microbiol Infect. 2020 Aug; 26(8):988-998.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.